ST Hulwa disclosed its semi-annual report on August 26. In the first half of 2026, the company achieved operating revenue of 241 million yuan, down 52.55 percent year-on-year. Net profit attributable to shareholders of the listed company was negative 113 million yuan, compared with a profit of 2.4098 million yuan in the same period last year, swinging from profit to loss year-on-year. During the reporting period, affected by the overall market environment and supply-demand dynamics among other factors, the company's operating revenue declined year-on-year.
Hainan Huluwa Pharmaceutical Group Co LtdFirst-half loss of 113 million yuan, revenue down 52.55% year-on-year.